|
|
Volumn 60, Issue 1, 2011, Pages
|
|
Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCG VACCINE;
MITOMYCIN C;
ANTINEOPLASTIC ANTIBIOTIC;
IMMUNOLOGICAL ADJUVANT;
MITOMYCIN;
BLADDER CANCER;
BLADDER CARCINOMA;
CANCER COMBINATION CHEMOIMMUNOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CARCINOMA IN SITU;
DISEASE FREE SURVIVAL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
HUMAN;
LETTER;
NON MUSCLE INVASIVE BLADDER CANCER;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
PROVOCATION TEST;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT FAILURE;
TREATMENT OUTCOME;
BLADDER TUMOR;
DRUG COMBINATION;
INTRAVESICAL DRUG ADMINISTRATION;
NOTE;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRAVESICAL;
ANTIBIOTICS, ANTINEOPLASTIC;
BCG VACCINE;
CARCINOMA IN SITU;
CLINICAL TRIALS, PHASE II AS TOPIC;
DRUG THERAPY, COMBINATION;
HUMANS;
MITOMYCIN;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
URINARY BLADDER NEOPLASMS;
|
|
EID: 79957955365
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2011.03.050 Document Type: Letter |
|
Times cited : (1)
|
|
References (3)
|
